Research on Prevention, Early Detection, and Clinical Evaluation of Intracranial Hemorrhage in Preterm Infants
ROPEDACEOIHIPI
A Multi-center and Multidisciplinary Research Project on Prevention, Early Detection, and Clinical Evaluation of Intracranial Hemorrhage in Preterm Infants
1 other identifier
interventional
300
0 countries
N/A
Brief Summary
- 1.Establish a reference curve for the lateral ventricular diameter of premature infants and determine the intervention threshold for hydrocephalus after hemorrhage in premature infants based on the reference curve, providing a scientific basis for optimizing clinical intervention.
- 2.Apply ultrasound radiomics technology to explore and formulate new standards for imaging diagnosis and treatment; By integrating metabolomics, ultrasound radiomics and clinical data, high-risk individuals for intracranial hemorrhage and their relationship with prognosis can be identified early.
- 3.To explore whether advancing the indication for surgical intervention of hydrocephalus in preterm infants after hemorrhage from ventricular index P97+4mm to P97 and whether repeated lumbar puncture and drainage can improve their prognosis, with the aim of clarifying the optimal timing for intervention of hydrocephalus in preterm infants after hemorrhage and optimizing the treatment methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedFirst Posted
Study publicly available on registry
September 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
September 5, 2025
September 1, 2025
1.3 years
August 26, 2025
September 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Death or the occurrence of neurodevelopmental disorders (NDI) before the corrected gestational age of 2 years.
NDI can be diagnosed if any of the following conditions are met. * Cerebral palsy; * Griffiths score \<85 points for the corresponding age: The assessment times are CA at 3 months, 6 months, 9 months, 12 months, 18 months, and 24 months respectively. Any assessment score lower than 85 points is considered a positive event. * Sensorineural or mixed hearing impairment and non-congenital hearing loss require hearing AIDS or cochlear implants ④ Bilateral visual impairment; * Epilepsy.
The assessment times are CA at 3 months, 6 months, 9 months, 12 months, 18 months, and 24 months respectively.
Study Arms (2)
Low-threshold intervention group
EXPERIMENTALVI\>P97,but ≤ P97+4mm
high-threshold intervention group
EXPERIMENTALVI\>P97+4mm
Interventions
Intervention criteria: Low-threshold intervention group and high--threshold intervention group
Eligibility Criteria
You may qualify if:
- Gestational age: 23+0 weeks to 36+6 weeks;
- Post-hemorrhagic hydrocephalus is confirmed by cranial ultrasound or other cranial imaging examinations.
- No cerebrospinal fluid drainage treatment was received before enrollment.
You may not qualify if:
- Excluding secondary IVH, including but not limited to congenital malformations, vitamin K1 deficiency, abnormal coagulation function, etc.
- Excluding hydrocephalus caused by other reasons, including but not limited to infection, congenital malformations, intracranial space-occupying lesions, etc.
- Treatment before diagnosis of hydrocephalus after intraventricular hemorrhage or suspected presence of central nervous system infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2025
First Posted
September 5, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
September 5, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share